The DOI matches its Crossref record.
Immune responses of specific pathogen free foals to EHV-1 infection.
Abstract
Four foals were raised under specific pathogen free (SPF) conditions. At 3 to 4 months of age, SPF foals and 1 other non-SPF foal were intranasally inoculated with equine herpes virus type 1 (EHV-1). Clinical signs included depression, fever, inappetence and intermittent coughing. Clinical recovery was complete by seven days but high titres of virus were detected in nasal mucus for at least 10 days after inoculation. Clinical illness was less severe in the non-SPF foal. Interferon was detected in the nasal mucus of all foals from 2 days post infection (dpi), persisting until 8 or 10 dpi. ELISA antibody was detected in serum from 6 dpi. Titres continued to rise throughout the period of observation, and were slightly stimulated by re-inoculation. EHV antibody, identified as belonging to the IgM class by the double sandwich ELISA, was detected from 6 dpi. Peak IgM titres were observed between day 10 and 18, declining to base levels by day 42. Virus neutralizing antibody was detectable in serum from day 14 and rises in titre were parallel to that of total ELISA antibody. Cellular immunity in EHV-1 infected SPF horses was examined by the antibody dependent cytotoxicity (ADCC) test and the specific lymphocyte transformation test. The ability of foal neutrophils to effect ADCC decreased significantly between 3 to 10 days after inoculation. Peripheral blood mononuclear cells (PBMC) displayed reactivity towards EHV-1 antigens from about day 14, with maximum stimulation indices being obtained between 28 and 42 dpi.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Equine type 1 interferon (IFNα/β) has been detected in nasal secretions and serum of experimentally EHV-1-infected ponies the first 2 weeks post-inoculation (Edington et al., 1989; Chong and Duffus, 1992).”
From The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1 (2021) · cites this paper as Chong and Duffus, 1992
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 60
- Allen, 1985, A new field strain of equine abortion virus (equine herpesvirus-1) among Kentucky horses, Am. J. Vet. Res., 46, 138
- Bridges, 1986, Innate immunity during equid herpesvirus (EHV-1) infection, Clin. Exp. Immunol., 65, 172
- Burrows, 1984, Trials of an inactivated equid herpesvirus 1 vaccine: Challenge with a subtype 1 virus, Vet. Rec., 114, 369, 10.1136/vr.114.15.369 · DOI
- Bryans, 1980, Serologic responses of pregnant Thoroughbred mares to vaccination with an inactivated equine herpesvirus 1 vaccine, Am. J. Vet. Res., 41, 1743
- Chong, 1991, The raising of colostrum-deprived foals: Maintenance and assessment of specific pathogen (EHV-1/4) free status, Equine Vet. J., 23, 111, 10.1111/j.2042-3306.1991.tb02733.x · DOI
- Clark, 1987, A method for the quantitative analysis of ELISA data, J. Virol. Methods, 15, 213, 10.1016/0166-0934(87)90099-1 · DOI
- Coignoul, 1984, Functional and ultrastructural changes in neutrophils from mares and foals experimentally inoculated with a respiratory tract strain of EHV1, Am. J. Vet. Res., 45, 1972
- Doll, 1968, Immunization against equine arteritis using modified live virus propagated in cell cultures of rabbit kidney, Cornell Vet., 58, 497
- Dutta, 1975, Immunity and the level of neutralization antibodies in foals and mares vaccinated with a modified live virus rhinnopneumonitis vaccine, Am. J. Vet. Res., 36, 445
- Fitzpatrick, 1984, Immunologic relationships between equine herpesvirus type one (equine abortion virus) and type four (equine rhinopneumonitis virus), Am. J. Vet. Res., 45, 1947
- Frank, 1989, Equine herpes outbreaks, Vet. Rec., 119, 471, 10.1136/vr.124.17.471-d · DOI
- Gleeson, 1980, Response of pregnant mares to equine herpesvirus 1 (EHV-1), Cornell Vet., 70, 401
- Mumford, 1986, Equid herpesvirus 1 (EHV 1) latency: More questions than answers, Equine Vet. J., 18, 340
- Mumford, 1984, Trials of an inactivated equid herpesvirus 1 vaccine: Challenge with a subtype 2 virus, Vet. Rec., 114, 375, 10.1136/vr.114.15.375 · DOI
- Ousey, 1984, Preliminary studies of mammary secretions in the mare to assess foetal readiness for birth, Equine Vet. J., 16, 259, 10.1111/j.2042-3306.1984.tb01923.x · DOI
- Reed, 1938, A simple method for estimating fifty per cent endpoints, Am. J. Hyg., 27, 493
- Sabine, 1989, Equine herpesvirus abortion in Australia 1977–1982, Equine Vet. J., 15, 366, 10.1111/j.2042-3306.1983.tb01825.x · DOI
- Steinhagen, 1988, Zur situationen der equinen herpesvirus typ 1 (EHV1)-infektion in der warmblutzucht Schleswig-Holsteins, Tierarztl. Umschau., 43, 348
- Babiuk, 1987, Protection of cattle from bovine herpesvirus type-1 (BHV-1) infection by immunization with individual viral glycoproteins, Virology, 159, 57, 10.1016/0042-6822(87)90347-3 · DOI
- Brake, 1985, Molecular epidemiology and pathogenesis of ruminant herpesviruses including bovine, buffalo and caprine herpesvirus 1 and bovine encephalitis herpesvirus, Aust. Vet. J., 62, 331, 10.1111/j.1751-0813.1985.tb07652.x · DOI
- Bitsch, 1978, The P37/24 modification of the infectious bovine rhinotracheitis virus-serum neutralization test, Acta. Vet. Scand., 19, 497, 10.1186/BF03547589 · DOI
- Bulach, 1990, Comparative genome mapping of bovine encephalitis herpesvirus, bovine herpesvirus 1, and buffalo herpesvirus, Arch. Virol., 113, 17, 10.1007/BF01318350 · DOI
- Burnette, 1981, ‘Western blotting’, electrophoretic transfer of proteins from SDS-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A, Anal. Biochem., 112, 195, 10.1016/0003-2697(81)90281-5 · DOI
- Collins, 1984, Neutralizing determinants defined by monoclonal antibodies on polypeptides specified by bovine herpesvirus 1, J. Virol., 52, 403, 10.1128/JVI.52.2.403-409.1984 · DOI
- Dawson, 1962, Infectious bovine rhinotracheitis (IBR). A clinical condition of cattle occurring in the United Kingdom, Vet. Rec., 74, 1379
- Ek-Kommonen, 1986, Isolation of a herpesvirus serologically related to bovine herpesvirus 1 from a reindeer (Rangifer tarandus), Acta Vet. Scand., 27, 299, 10.1186/BF03548174 · DOI
- Engels, 1983, Goat herpesviruses: Biological and physiochemical properties, J. Gen. Virol., 64, 2237, 10.1099/0022-1317-64-10-2237 · DOI
- Galfre, 1981, Preparation of monoclonal antibodies: Strategies and procedures, Methods Enzymol., 73, 3, 10.1016/0076-6879(81)73054-4 · DOI · Paper page
- Gibbs, 1977, Bovine herpesviruses. Part I. Bovine herpesvirus 1, Vet. Bull., 47, 317
- Highlander, 1987, Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration, J. Virol., 61, 3356, 10.1128/JVI.61.11.3356-3364.1987 · DOI
- Horimoto, 1990, Feline herpesvirus type 1 glycoproteins eliciting virus neutralizing and haemagglutination-inhibition antibodies, Arch. Virol., 111, 127, 10.1007/BF01310510 · DOI
- Hughes, 1988, Functional and topographical analysis of epitopes on bovine herpesvirus type-1 glycoprotein gIV, Arch. Virol., 103, 47, 10.1007/BF01319808 · DOI
- Inglis, 1983, Ocular disease in red deer calves associated with a herpesvirus infection, Vet. Rec., 113, 182, 10.1136/vr.113.8.182 · DOI
- Israel, 1988, Epitope specificity and protective efficacy of the bovine immune response to bovine herpesvirus-1 glycoprotein vaccines, Vaccine, 349, 10.1016/0264-410X(88)90182-X · DOI
- Kohler, 1975, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature (London), 256, 495, 10.1038/256495a0 · DOI · Paper page
- Kohler, 1976, Fusion between immunoglobulin secreting and non-secreting myeloma cell lines, Eur. J. Immunol., 6, 292, 10.1002/eji.1830060411 · DOI · Paper page
- Laemmli, 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature (London), 227, 680, 10.1038/227680a0 · DOI · Paper page
- Lyaku, 1990, A quantitative enzyme-linked immunosorbent assay for bovine herpesvirus type 1 (BHV-1) antibody, Biologicals, 18, 199, 10.1016/1045-1056(90)90007-M · DOI
- Marshall, 1986, Characterization of envelope proteins of infectious bovine rhinotracheitis virus (bovine herpesvirus 1) by biochemical and immunological methods, J. Virol., 57, 745, 10.1128/JVI.57.3.745-753.1986 · DOI
- Martin, 1990, A serological comparison of some animal herpesviruses, Comp. Immunol. Microbiol. Infect. Dis., 13, 75, 10.1016/0147-9571(90)90519-Y · DOI
- Metzler, 1979, Herpesvirus-infektion bei Zincklein in des Schweiz, Schweiz. Arch. Tierheilk., 121, 661
- Metzler, 1985, European isolates of bovine herpesvirus 1: A comparison of restriction endonuclease sites, polypeptides and reactivity with monoclonal antibodies, Arch. Virol., 85, 57, 10.1007/BF01317006 · DOI
- Metzler, 1986, Bovine herpesvirus 1: Molecular and antigenic characteristics of variant isolated from calves with neurological disease, Arch. Virol., 87, 205, 10.1007/BF01315300 · DOI
- Miller, 1988, Effects of a bovine herpesvirus-1 isolate on reproductive function in heifers: Classification as a type 2 (infectious pustular vulvovaginitis) virus by restriction endonuclease analysis of viral DNA, Am. J. Vet. Res., 49, 1653
- Miller, 1991, Abortificent property of bovine herpesvirus type 1 isolates that represent three subtypes determined by restriction endonuclease analysis of viral DNA, Am. J. Vet. Res., 52, 458
- Misra, 1983, Analysis of bovine herpesvirus-type 1 isolates by restriction endonuclease finger printing, Arch. Virol., 76, 341, 10.1007/BF01311201 · DOI
- Nettleton, 1980, Infectious bovine rhinotracheitis virus excretion after vaccination, Vet. Rec., 107, 379, 10.1136/vr.107.16.379 · DOI
- Nettleton, 1983, Comparison of an immunofluorescent test and an ELISA for the rapid diagnosis of infectious bovine rhinotracheitis in experimentally infected animals, Cur. Top. Vet. Med. Anim. Sci., 22, 132
- Nixon, 1988, Serological comparison of antigenically related herpesviruses in cattle, red deer and goats, Vet. Res. Commun., 12, 355, 10.1007/BF00343256 · DOI
- Okazaki, 1986, Mechanisms of neutralization by monoclonal antibodies to different antigenic sites on the bovine herpesvirus 1 glycoproteins, Virology, 150, 260, 10.1016/0042-6822(86)90285-0 · DOI
- Pastoret, 1988, Diseases of wild animals transmissible to domestic animals, Rev. Sci. Tech. Off. Int. Epiz., 7, 705
- Prabhakar, 1982, High frequency of antigenic variations among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies, Nature (London), 300, 374, 10.1038/300374a0 · DOI
- Ronsholt, 1987, Latent herpesvirus infection in red deer: characterization of a specific deer herpesvirus including comparison of genomic restriction fragment patterns, Acta Vet. Scand., 28, 23, 10.1186/BF03548253 · DOI
- Schudel, 1986, Infections of calves with antigenic variants of bovine herpesvirus-1 (BHV-1) and neurological disease, J. Vet. Med. B., 33, 303, 10.1111/j.1439-0450.1986.tb00036.x · DOI
- St. George, 1972, Isolation of infectious bovine rhinotracheitis virus from the prepuce of water buffalo bulls in Australia, Aust. Vet. J., 48, 126, 10.1111/j.1751-0813.1972.tb02244.x · DOI
- Trepanier, 1986, Bovine herpesvirus-1 strain comparison of polypeptides and identification of a neutralizing epitope on the 90 kilodalton hemagglutinin, J. Virol., 60, 302, 10.1128/JVI.60.1.302-306.1986 · DOI
- van Drunen Littel-van den Hurk, 1984, Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: Characterization of their biochemical and immunological properties, Virology, 135, 466, 10.1016/0042-6822(84)90201-0 · DOI
- van Drunen Littel-van den Hurk, 1985, Antigenic and immunogenic characteristics of bovine herpesvirus type-1 glycoproteins (GVP3/9 and GVP 6/11 a/16, purified by immunoadsorbent chromatography, Virology, 144, 204, 10.1016/0042-6822(85)90318-6 · DOI
- van Drunen Littel-van den Hurk, 1990, The role of carbohydrate in the antigenic and immunogenic structure of bovine herpesvirus type 1 glycoproteins gI and gIV, J. Gen. Virol., 71, 2053, 10.1099/0022-1317-71-9-2053 · DOI
- Yates, 1982, A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral bacterial synergism in respiratory disease of cattle, Can. J. Comp. Med., 46, 225
Cited by
The Pathogenesis and Immune Evasive Mechanisms of Equine Herpesvirus Type 1
Laval, K., Poelaert, K. C. K., Van Cleemput, J., Zhao, J., Vandekerckhove, A. P., Gryspeerdt, A. C., Garré, B., van der Meulen, K., Baghi, H. B., Dubale, H. N., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.662686 · Cited by 54
Metadata
- Authors
- Chong, Y. C., & Duffus, W. P. H.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Duffus, W.P.H.
- Venue
- Veterinary Microbiology
- Publisher
- Elsevier BV
- Published
- 1992-10
- Volume
- 32
- Issue
- 3-4
- Pages
- 215-239
- ISSN
- 0378-1135 (ISSN-L)
- OpenAlex
- W1969326874
- Cited by
- 26
- References
- 0
- Citations by year
- 2024: 4 · 2022: 1 · 2021: 1 · 2015: 1 · 2014: 1 · 2013: 2
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Veterinary Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- equine herpesvirus 1, foals, immune response, interferon, IgM, virus-neutralizing antibodies, antibody-dependent cellular cytotoxicity, lymphocyte transformation, cell-mediated immunity, peripheral blood mononuclear cells, neutrophils, reinfection, nasal mucus
- MeSH terms
- Animals, Antibodies, Viral, Antibody-Dependent Cell Cytotoxicity, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Herpesvirus 1, Equid, Herpesviridae Infections, Horse Diseases, Horses, Immunoglobulin M, Interferons, Lymphocyte Activation, Neutralization Tests, Neutrophils, Specific Pathogen-Free Organisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.